Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Matthew R Trendowski"'
Autor:
Mohammad Shahbazi, Xindi Zhang, Paul C. Dinh, Victoria A. Sanchez, Matthew R. Trendowski, Megan M. Shuey, Tessa Nguyen, Regeneron Genetics Center, Darren R. Feldman, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Neil E. Martin, Lawrence H. Einhorn, Nancy J. Cox, Robert D. Frisina, Lois B. Travis, Mary Eileen Dolan
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2999-3012 (2023)
Abstract Purpose Deficits in speech understanding constitute one of the most severe consequences of hearing loss. Here we investigate the clinical and genetic risk factors for symmetric deterioration of speech recognition thresholds (SRT) among cance
Externí odkaz:
https://doaj.org/article/aedaa37449a4452f9310279b835a3e66
Autor:
Matthew R. Trendowski, Jaclyn M. Kyko, Christine M. Lusk, Julie J. Ruterbusch, Theresa A. Hastert, Felicity W. K. Harper, Hayley Thompson, Jennifer L. Beebe‐Dimmer, Ann G. Schwartz
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 684-695 (2023)
Abstract Background Epidemiological studies of cancer survivors have predominantly focused on non‐Hispanic White, elderly patients, despite the observation that African Americans have higher rates of mortality. Therefore, we characterized cancer su
Externí odkaz:
https://doaj.org/article/15ccbf7a4bc34a54a4a944e40c5467b4
Autor:
Xindi Zhang, Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey, Regeneron Genetics Center, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E. Martin, Victoria A. Sanchez, Robert D. Frisina, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis, M. Eileen Dolan
Publikováno v:
Cancer Medicine, Vol 11, Iss 14, Pp 2801-2816 (2022)
Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities amon
Externí odkaz:
https://doaj.org/article/44f25d0b9c9c44fea27f757e2ecf0dda
Autor:
Matthew R. Trendowski, Christine M. Lusk, Julie J. Ruterbusch, Randell Seaton, Michael S. Simon, Mark K. Greenwald, Felicity W. K. Harper, Jennifer L. Beebe‐Dimmer, Ann G. Schwartz
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8151-8161 (2021)
Abstract Background Epidemiological studies of chemotherapy‐induced peripheral neuropathy (CIPN) have predominantly focused on non‐Hispanic White patients, despite the observation that African Americans are more likely to experience CIPN. To addr
Externí odkaz:
https://doaj.org/article/f7126e1a2b374146bee112253b537bb1
Autor:
M. Eileen Dolan, Lois B. Travis, Lawrence H. Einhorn, Sophie D. Fossa, Patrick Monahan, Shirin Ardeshir-Rouhani-Fard, Robert Huddart, Nancy J. Cox, Eric R. Gamazon, Michiaki Kubo, Taisei Mushiroda, Christian Kollmannsberger, Chunkit Fung, David J. Vaughn, Robert J. Hamilton, Darren R. Feldman, Robert D. Frisina, Paul C. Dinh, Claudia Wing, Heather E. Wheeler, Matthew R. Trendowski, Brandon Mapes, Omar El Charif
Supplementary data from Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034c3a2bc9c14bb6ef3619c01b3cf774
https://doi.org/10.1158/1078-0432.22470240
https://doi.org/10.1158/1078-0432.22470240
Autor:
M. Eileen Dolan, Lois B. Travis, Lawrence H. Einhorn, Christian Kollmannsberger, Chunkit Fung, David J. Vaughn, Robert J. Hamilton, Darren R. Feldman, Omar El-Charif, Heather E. Wheeler, Matthew R. Trendowski
The design of the study, GWAS results, clinical characteristics are included in the supplemental data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691ac15379c2662eb29c3ea2802d4a91
https://doi.org/10.1158/1078-0432.22477103.v1
https://doi.org/10.1158/1078-0432.22477103.v1
Supplementary Table S1 and S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019c8c8ef65a82865ae6bb166fb591ef
https://doi.org/10.1158/1078-0432.22468260.v1
https://doi.org/10.1158/1078-0432.22468260.v1
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent, which has potent antineoplastic activity due to its affinity for DNA and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d02673c15d7e31a0f9fd95dd0d65825
https://doi.org/10.1158/1078-0432.c.6526878
https://doi.org/10.1158/1078-0432.c.6526878
Autor:
M. Eileen Dolan, Lois B. Travis, Lawrence H. Einhorn, Sophie D. Fossa, Patrick Monahan, Shirin Ardeshir-Rouhani-Fard, Robert Huddart, Nancy J. Cox, Eric R. Gamazon, Michiaki Kubo, Taisei Mushiroda, Christian Kollmannsberger, Chunkit Fung, David J. Vaughn, Robert J. Hamilton, Darren R. Feldman, Robert D. Frisina, Paul C. Dinh, Claudia Wing, Heather E. Wheeler, Matthew R. Trendowski, Brandon Mapes, Omar El Charif
Purpose:Cisplatin, a commonly used chemotherapeutic, results in tinnitus, the phantom perception of sound. Our purpose was to identify the clinical and genetic determinants of tinnitus among testicular cancer survivors (TCS) following cisplatin-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c57552535da8e5e53525afdbee8a6cf
https://doi.org/10.1158/1078-0432.c.6527475.v1
https://doi.org/10.1158/1078-0432.c.6527475.v1
Autor:
M. Eileen Dolan, Lois B. Travis, Sophie D. Fossa, Lawrence H. Einhorn, Frederick Strathmann, Robyn Hannigan, Michiaki Kubo, Taisei Mushiroda, Christian Kollmannsberger, Chunkit Fung, David J. Vaughn, Robert J. Hamilton, Shirin Ardeshir-Rouhani-Fard, Darren R. Feldman, Paul C. Dinh, Heather E. Wheeler, Zepeng Mu, Patrick Monahan, Mark J. Ratain, Omar El-Charif, Matthew R. Trendowski
Purpose:Serum platinum is measurable for years after completion of cisplatin-based chemotherapy (CBC). We report the largest investigation of serum platinum levels to date of 1,010 testicular cancer survivors (TCS) assessed 1–35 years after CBC and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::095680b29ddc9424920d2b6f96e813f5
https://doi.org/10.1158/1078-0432.c.6528639.v1
https://doi.org/10.1158/1078-0432.c.6528639.v1